Arrhythmia Flashcards

(103 cards)

1
Q

Reverse use dependence

A
Increased effect at slow heart rates 
All class III drugs including dofetilide 

III: block outward potassium channel activity (IKs) and prolong refractoriness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dofetilide side effects

A

Hypomagnesemia, hypokalemia, QT prolongation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pacemaker cardiomyopathy

A

12% of patients who are paced >20% of the time-> change or upgrade to biventricular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ventricular pacing alone (without atrial pacing) increases

A

Afib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Management of LQTS

A
Genetic testing of index patient 
Beta blockers 
ICDs if strong personal risk factors for SCD 
QTC > 480ms more definitive 
Polymorphic VT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Persistent afib
Paroxysmal
Long-standing persistent
Permanent

A

> 7 days
<7 days
12 months
We have stopped attempts to control and accepted it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Primary prevention ICD (MADIT-II trial)

A

Just EF and GDMT?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CRT (biventricular ICD) indication

A

EF <35%, QRS> 150, LBBB, sinus rhythm, class II-IV despite GDMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Palpitations work up

24 hour holter vs event monitor

A

If risk factors for cardiac disease, attempt to correlate with monitor

Event monitor generally shown to be better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Palpitations and lightheaded ness with exercise and emotion in young person, positive family history

A

CPVT

Ryanodine receptor mutation more common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Transforming growth factor-beta (TGF-β) mutations

A

Familial thoracic aortic aneurysms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fibrillin mutation

A

Marfan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Myosin heavy chain mutation

A

HCOM and dilated cardiomyopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Plakophilin mutation

A

ARVC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Monomorphiv VT that originates in RVOT

Differential

A

LBBB morphology (down in V1) with inferior axis, can ablate / BB/ CCB/ class 1C

idiopathic VT and arrhythmogenic right ventricular cardiomyopathy (ARVC)

RVOT VT is usually not ischemia driven

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ARVC

A

Epsilon wave after QRS and TWIs in V1-V3

Get CT/MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Arrhythmias in Brugada

A

Beta blockers CI- increase ST elevation
Amiodarone is pro arrhythmic

Treat fever, avoid drugs and alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Quinidine for

A

ICD w/ multiple shocks for VT

ICD is CI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

LVOT VT

A

LBBB, inferior axis, early R wave progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

VT in structurally normal heart

VT in abnormal heart

A

Meds or ablate

ICD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Most common cause of VT (wise complex, positive concordance, monophasic R in V1) in CAD

A

Scar-mediated, re-entrant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Torsades in LQTS mechanism

A

Early afterdepolarizations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Mobitz type II vs complete heart block

A

Fixed PR interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Brugada

A

Sodium channel blockers (flecainide, propafenone) can exacerbate the transient ECG abnormalities that occur in patients with Brugada syndrome who commonly have normal ECGs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
AF with aberrancy, WPW | Do not give
Beta blocker, adenosine, dig. | Use ibitulide and procainamide
26
AF with WPW vs plain AF
Wide complex vs narrow complex
27
2:1 block, differentiate between Mobitz I and II
I may be due to increased vagal tone in athletes- improves with exercise II is due to His disease- worsens with exercise
28
atrial tachycardia, atrial flutter, or atrial fibrillation in adult congenital heart disease patients
progressive hemodynamic deterioration of the underlying disease Obtain TTE and address arrhythmia
29
Marked first degree AV block can cause fatigue
>300, cannon a waves Due to AV dyssynchrony- atrium contracts before complete filling-> decreased ventricular filling May benefit from pacing
30
Cardio inhibitory syncope
Vagally mediated
31
Sotalol side effect
Non sustained torsades
32
Sotalol
Class III Blocks inward potassium channel, prolongs QT Risk is higher in bradycardia, female sex, pre-existing QT prolongation, history of heart failure, history of ventricular tachycardia/ventricular fibrillation, or hypokalemia.
33
Sustained torsades treatment
If unstable- shock If stable- IV mag ``` IV isoproterenol (increases HR, decreases QT) No beta blockers or amiodarone ```
34
Underlying causes of afib
hypertension, obstructive sleep apnea, and obesity
35
AV block (complete heart block) vs AV dissociation (AIVR)
Atrial rate is faster | Ventricular rate is faster
36
Tachy Brady syndrome
Post AF conversion pause - sinus node dysfunction + afib | Avoid sodium channel blockers like flecainide
37
ARVC lifestyle
high risk of ventricular arrhythmias and sudden death avoid competitive sports and endurance training Can do billiards, bowling, cricket, curling, golf, and riflery Consider family screening, may need ICD
38
Polymorphic (multiple QRS morphology) tachy risk factors Drugs Ischemia is a common cause
baseline QT prolongation, bradycardia, and electrolyte disturbances (especially hypokalemia and hypomagnesemia, and less often hypocalcemia). Levo and albuterol
39
Non–isthmus-dependent (atypical) atrial flutter mechanism Underlying etiology Treatment
macro–re-entrant circuits elsewhere in the RA or LA congenital heart disease, after cardiac surgery, and after catheter ablation of AF. Rate control-> EPS
40
Afib mechanism AVNRT mechanism
Rapid focal ectopic activity (pulmonary veins) Re-entry within triangle of Koch
41
Type 1 Brugada, sudden death in family member
ICD is not indicated | Indicated in personal history of cardiac arrest or syncope (at rest, not vasovagal)
42
Typical atrial flutter vs atypical
Sawtooth in inferior leads, positive in V1: cavotricuspid, can be ablated Fossa ovalis or SVC
43
Acute renal failure, stop
Atenolol, accumulates
44
ARVC VT | Idiopathic RVOT VT
Beta blocker -> ablation | Ablation
45
Afib underlying causes
hyperthyroidism, pericarditis, pulmonary embolism, and electrolyte abnormalities (r/o)
46
AVNRT
Most frequent SVT, Cannon a waves (neck discomfort) AVRT Atrial tachycardia
47
Narrow complex regular tachycardia
``` SVT: AVNRT (dual pathway) AVRT (accessory pathway) AT (ectopic Ps, organized atrial activity with adenosine) Sinus tachycardia Junctional tachycardia ```
48
Narrow complex irregularly irregular tachycardia
AF MAT Sinus arrhythmia Any pattern= regularly irregular
49
Flutter or fib for less than 48 hours
Can be DC cardioverted without TEE * Rate control is difficult in flutter, aim for rhythm control if possible* (cardioversion preferred)
50
Brugada type 2 (saddle back)/ 3
ECG with superior placement of V1 and V2/ block sodium channels with flecainide to unmask Provocative testing such as drug challenge with procainamide or flecainide or programmed electrical stimulation during electrophysiology testing
51
Prolonged QT-> PMVT-> vfib mechanism
Early after depolarizations | Hydroxychloroquine
52
PMVT due to acute ischemia mechanism
causes re-entry due to loss of the epicardial action-potential dome in phase II.
53
Treatment of recurrent symptomatic SVT
Ablation
54
Fever, alcohol and cocaine unmask Brugada Gene mutation
SCN5A
55
PVC ablation | Work up
>25% | Holter monitor-> implantable loop recorder
56
Inappropriate sinus tachy treatment
Ivabradine (if current in SA node, drives sinus rate) | Beta blockers not effective
57
Sinus node dysfunction
persistent sinus bradycardia , chronotropic incompetence, paroxysmal or persistent sinus arrest with replacement by subsidiary escape rhythms in the atrium, atrioventricular (AV) junction, or ventricular myocardium
58
Chronotropic incompetence Deconditioning
peak heart rate <100 bpm and <70% age-predicted maximum heart rate. Exaggerated HR response during exercise
59
First degree vs Mobitz I vs Mobitz II
No dropped ps vs increased PR, narrow complex vs normal PR, sometimes wide qrs
60
Mobitz I vs Mobitz II
AV nodal block vs His Carotid sinus massage worsens AV block, improve His conduction Exercise improves AV conduction, worsens His
61
Flecainide/ propafenone Sotalol
Class Ic, Na blocker Dissociate slowly during diastole-> use dependence Effective for pill in pocket SVT can exacerbate underlying conduction system disease, unmasking sinus node dysfunction (post conversion pause), atrioventricular block, or infrahisian block, and increases in the P-R and QRS intervals of ≤25% Class III, potassium channel blocker Reverse use dependence, effective at slower heart rates, use daily
62
Afib > 48 hours | Post cardioversion anticoagulation (there is risk with cardioversion)
``` Anticoagulate and TEE before cardioversion 4 weeks (Long term AC is determined by CV score) ```
63
VT/ NSVT/ PVCs: Negative in V1( left bundle morphology) Positive in V1( right bundle morphology)
Differentiate normal heart from structural heart disease ``` RVOT (idiopathic vs ARVC) Left ventricle (different morphologies= cardiomyopathy) ``` ICD if there is structural heart disease
64
Bidirectional VT
Digoxin toxicity (dronaderone increases, so does amiodarone) Amiodarone and warfarin also = drug interaction
65
WPW EKG EKG+ symptoms If uninterested in ablation
Noninvasive exercise testing to risk stratify Disappearance of delta wave = low risk Persistent, gradual shortening= high risk Straight to ablation, no need for stress test If no SHD, beta blocker / CCB, flecainide or propafenone
66
Afib+ asymptomatic, normal EF Target HR
Rate control and AC Can consider ablation if symptomatic or decreases EF <110 (RACE-II)
67
Rate control = rhythm control | Factors to consider
age (rate in older), symptoms (rhythm?), duration of AF (>48 hrs- rate) evidence of tachycardia-mediated cardiomyopathy (rhythm), or difficulty in achieving adequate rate control.???
68
Permanent AF | Can prevent effective pacing
Can not restore sinus, so no need for antiarrhythmic drugs | Can ablate AV junction for rate control
69
Pacing + LBBB | No response to CRT causes
RV pacing only atrial fibrillation with rapid conduction, inappropriate device programming, and frequent ventricular ectopy, loss of LV lead capture or poor LV lead position Response depends on >90% biv pacing
70
CV risk of stroke
Corresponds till 4, then sequential increase 5_->7, 6-> 9, 7-> 10, 9-> 15
71
SCD during swimming LQTS syndrome treatment
Long QTS Loss of function in potassium channel-> delay in membrane repolarization Beta blocker -> ICD
72
AF/flutter + HCOM
AC regardless of CV score
73
1st / 2nd degree Brugada relative with normal ECG
Genetic testing
74
PMVT-> acute ischemia
ongoing chest pain with a normal ECG can be seen with an acute circumflex artery occlusio
75
Monomorphic VT mechanism
Re-entry around a scar Or Single focus in structural heart disease
76
BRUISE CONTROL
peridevice surgery anticoagulation | Warfarin better than lovenox
77
Sinus node dysfunction types
symptomatic bradycardia, sinus pauses due to sinus arrest or sinoatrial exit block, and chronotropic incompetence.
78
RVOT PVCs
LBBB with inferior axis and late R-wave progression, beyond V3 Ablate
79
Irreversible symptomatic Brady due to SND or AV block (both types of second degree )
Pacemaker
80
HCOM ICD
prior cardiac arrest/ sustained VT/ first degree SCD/ wall thickness >30 mm/ unexplained syncope * do not do dobutamine stress= increase LVOT gradient-dangerous*
81
Unexplained syncope
Investigate with monitoring for arrhythmia and echo for LV dysfunction
82
LQTS genetic testing
Strong clinical suspicion for LQTS and qt prolongation | Asymptomatic, idiopathic qtc >500/480 /460
83
Prolonged qtc underlying causes
Bundle branch block, meds
84
WPW treatment
Procainamide, ibutilide, cardioversion | No amiodarone or lidocaine
85
Predicted max HR Goal max HR Chronotropic incompetence
220-Age (220-Age)* 0.85 Inability to reach 80%
86
Atrial tachycardia treatment
Ablate If resistant, beta blockers, nondihydro
87
MNVT mechanism RVOT VT mechanism Torsades mechanism
Scar mediated re-entry Delayed and early afterdepolarization Early afterdepolarization
88
Timolol eye drops can cause
Brady arrhythmia in drug interactions with paroxetine for example Rule out drugs before diagnosing SND
89
VT SHD No SHD
ICD | Drugs or ablation
90
Left ventricle fascicular VT
Re entrant tachy Sensitive to verapamil Can ablate
91
Characteristic of wenckebach
Short PR after dropped P
92
Hyperkalemia
Peaked T, wide QRS, prolonged PR
93
Hypokalemia ECG
U wave
94
bradycardia treatment
``` hemodynamically unstable, third-degree AV block with escape rates <40 bpm: transcutaneous pacing Infra nodal (wide qrs, Mobitz II onwards): isoproterenol, will need pacemaker eventually AV nodal (narrow qrs, first degree, Mobitz I): atropine dopamine? ```
95
advanced degree AV block
2 or more consecutive ps are blocked
96
1 second on ecg strip | infranodal block
5 large boxes | wide qrs, mobitz II onwards (can be mobitz I)
97
posterior fascicular VT | anterior fascicular VT
RBBB+ LAD | RBBB+ RAD
98
2:1 block
Differentiate b/w Mobitz I vs II with carotid sinus massage or ETT
99
Regularization of QRS in afib
Complete heart block
100
Indeterminate axis differential
LAFB+ RVH
101
Regularization of QRS in afib
Complete heart block
102
Indeterminate axis differential
LAFB+ RVH
103
Electrical storm treatment
Propanol